PRPO
Precipio, Inc. Common Stock
LABORATORY ANALYTICAL INSTRUMENTS
Best Lab Instruments Stocks 2026 →
Precipio (PRPO) Stock: Buy, Sell, or Hold?
$24.80
+1.15 (+4.86%)
▲
5d:
+26.72%
30d:
+9.78%
90d:
+6.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (16%)
Quality Score
28/100
Position
EXTENDED
30-Day Fair Range
$19.11 – $23.20
Position: EXTENDED
Forward P/E & Valuation
15.4x
Next 12M consensus est.
Wall Street Target
$19.00
-23.4% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$17.79 / $25.34
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PRPO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $24.80, which is considered extended relative to its 30-day fair value range of $19.11 to $23.20.
Technical Outlook: Technically, PRPO is in a downtrend. The price is approaching resistance at $25.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: PRPO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPO is in a downtrend. The price is approaching resistance at $25.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: PRPO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.11 -
$23.20
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
15.8%
Trading Range & Key Levels
30-Day Trading Range
$19.11 -
$23.20
Current vs Trading Range
EXTENDED
Support Level
$17.79
Resistance Level
$25.34
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+6.9% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BEARISH: Trading 23.4% above Wall St target ($19.00)
- WARNING: Composite score 28/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-23.4%)
Revenue Growth (YoY)
24.2%
Profit Margin
-4.5%
Share PRPO Analysis
Share this live PRPO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRPO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Specialty cancer diagnostics company Precipio reported record Q3 revenue of $7.3M, positive Adjusted EBITDA, and a cash balance exceeding $3.5M, signaling financial strengthening and potential for future growth.
Key Retail Themes:
financial performance
growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:25 PM ET
Data refreshes hourly during market hours. Next update: 5:25 PM
Data refreshes hourly during market hours. Next update: 5:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRPO Research Pages
